Newsletter

Consult the publication in which ETAP-LAB was mentioned and acknowledged for our in vitro hippocampal neuron model—challenged with own-manufactured Tau oligomers: "A novel allosteric GCase modulator prevents Tau accumulation in GBA1WT and GBA1L444P/L444P cellular models. Sci Rep 15, 17646 (2025)." Published 21 May 2025 - Ciccaldo, M., Pérez-Carmona, N., Piovesana, E. et al. https://www.nature.com/articles/s41598-025-02346-8 Authors: Matteo Ciccaldo1, Natàlia Pérez-Carmona2, Ester Piovesana1, Sara Cano-Crespo2, Ana Ruano2, Aida Delgado2, Ilaria Fregno3, Beatriz Calvo-Flores Guzmán4, Manolo Bellotto4, Maurizio Molinari3,5, Joanne Taylor6, Stéphanie Papin1, Ana María

By

Dr Jean-François BISSON, PhD, and Lianna RAZAFITRIMO, presented the team’s research during the SPIN 2025 (Congress of the Skin Inflammation & Psoriasis International Network)  in the poster: "Behavioural assessment as a tool for evaluation of efficacy therapies associated with well-being recovery in preclinical models of skin diseases".   Learn more about our preclinical services in Dermatology in the poster! Until the poster is available here, don’t wait any longer and ask for the poster in PDF!   Authors: J.-F. Bisson, S. Hidalgo, L. Razafitrimo, L. Magadoux, L.

By

Neurology poster at the AFSSI Connexions 2025   ETAP-Lab will be present at the AFSSI Connexions 2025 in Toulouse on July 1 and 2 to present the poster resulting from the research work of the laboratory dedicated to Neurology and Neurodegenerative Diseases.   Healthcare R&D and Innovation: French preclinical CROs at the heart of European leadership AFSSI (the French Association of Service and Innovation Companies), in partnership with AD'OCC, the Occitanie region's economic development agency, is organizing the 12ᵉ edition of AFSSI Connexions on July

Preclinical Dermatology - Discover our Poster at SPIN 2025 Congress in Paris ETAP-Lab will be presenting a poster during the next edition of the SPIN 2025 Congress, organized every 3 years by the René Touraine Foundation, focused on Skin Inflammation & Psoriasis diseases. Let's talk inflammation at SPIN with our poster on our reference models using our unique translational approach focused on assessing rodent behavior and well-being. We share an overview of over 10 years of study results, showing just how reproducible

Dr Valentin TALLANDIER, in vitro Preclinical Project Leader, presented the team’s research during the MPS World Summit 2025 in Brussels in his poster.   Learn more about our high-thoughput capacitites for neurogenerative diseases in the poster! Until the poster is available here, don’t wait any longer and ask for the poster in PDF!   Authors: Valentin TALLANDIER, Ahmad ALLOUCHE, Julie COLIN, Léane Dier, Sonia KRIDI, Nicolas VIOLLE   Abstract: Synaptic plasticity alterations are a hallmark of cognitive decline in neurodegenerative diseases (NDD). Synaptic loss occurs at early stages of the

By

Booth & Partnering at BIO Convention 2025 in Boston   Our team will be at BIO 2025 in Boston (June 16-19), the right spot for Health Innovation! 📌 You can visit us at Booth 1935 with Eurobiomed, you'll meet Jerome Bernard and Sandra Robelet. 📆 We are partnering at BIO Convention 2025. You can connect through the BIO Partnering™ system and book a meeting to explore how we can support you in your drug development as a preclinical CRO.   "As a CRO, we have to

Meet our expert during the poster session As preclinical CRO expert in neuroscience research, we are delighted to participate in the 4th MPS Microphysiology Systems World Summit to present our research poster on our microfluidic platform dedicated to Neurodegenerative diseases (NDDs). When: from June, 9 to 13. Where: Brussels, Belgium. Poster session: Poster Session 4: Thursday June 12 Afternoon - Board 277. Track 2: MPS for Biomedical Research and Disease Modelling. Theme 2.5: Understanding the brain with MPS Dr Valentin TALLANDIER, in vitro Preclinical Project

100% of Customer Satisfaction in 2024 We’re proud to share that in 2024, we achieved a 100% customer satisfaction rate, with an average score of 9.3 out of 10. It's important for us to establish a trustful and long-lasting relationship with our customers. That’s why we asked our customers to evaluate the quality of their collaboration with us throughout the 2024 studies. The results speak for themselves: 100% of respondents reported being fully satisfied with their experience working with ETAP-Lab and our

Dr Ahmad Allouche, Head of in vitro biology, presented the team’s research* during at Venusberg Neuroinflammation Meeting 2025 in Luxembourg in his poster “NEUROINFLAMMATION MODELS OF NEURODEGENERATIVE DISEASES“. Learn more about our cutting-edge platform for target identification & drug discovery in the poster! Until the poster is available here, don’t wait any longer and ask for the poster in PDF!   *Ahmad ALLOUCHE, Valentin TALLANDIER, Léane DIER, Sonia KRIDI, Julie COLIN, Nicolas VIOLLE.